Quantity size:
0.2ml
Concentration:
1mg/ml NLRP8蛋白抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
NALPs are cytoplasmic proteins that form a subfamily within the larger CATERPILLER protein family. Most short NALPs, such as NALP8, have an N-terminal pyrin (MEFV; MIM 608107) domain (PYD), followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. The long NALP, NALP1 (MIM 606636), also has a C-terminal extensionNLRP8蛋白抗体 containing a function to find domain (FIIND) and a caspase recruitment domain (CARD). NALPs are implicated in the activation of proinflammatory caspases (e.g., CASP1; MIM 147678) via their involvement in multiprotein complexes called inflammasomes (Tschopp et al., 2003 [PubMed 12563287]).[supplied by OMIM, Mar 2008]
NLRP8蛋白抗体Also known as:
CLR19.2; NACHT domain-, leucine-rich repeat-, and PYD-containing protein 8; NACHT, leucine rich repeat and PYD containing 8; NACHT, LRR and PYD containing protein 8; NACHT, LRR and PYD domains-containing protein 8; NALP8; NALP8_HUMAN; NLR family, pyrin domain containing 8; NLRP8; NOD16; Nucleotide-binding oligomerization domain protein 16; Nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 8; PAN4;NLRP8蛋白抗体 PYRIN and NACHT-containing protein 4; PYRIN domain- and NACHT domain-containing protein 4.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human NLRP8.
●
NLRP8蛋白抗体Predicted Molecular Weight: 119kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl259Bo01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)
kl259Ga01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)
kl259Hu01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)
kl259Mu01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)
kl259Ra01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)
kl259Si01膜联蛋白A5(ANXA5)多克隆抗体Polyclonal Antibody to Annexin A5 (ANXA5)
kl260Si01β2-微球蛋白(β2M)多克隆抗体Polyclonal Antibody to Beta-2-Microglobulin (b2M)
kl262Hu01转铁蛋白受体2(TFR2)多克隆抗体Polyclonal Antibody to Transferrin Receptor 2 (TFR2)
kl262Mu01转铁蛋白受体2(TFR2)多克隆抗体Polyclonal Antibody to Transferrin Receptor 2 (TFR2)
kl262Ra01转铁蛋白受体2(TFR2)多克隆抗体Polyclonal Antibody to Transferrin Receptor 2 (TFR2)
kl263Bo01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)
kl263Ga01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)
kl263Hu01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)
kl263Mu01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)
kl263Po01线粒体肌酸激酶1A(CKMT1A)多克隆抗体Polyclonal Antibody to Creatine Kinase, Mitochondrial 1A (CKMT1A)
kl266Hu01热休克蛋白47(HSP47)多克隆抗体Polyclonal Antibody to Heat Shock Protein 47 (HSP47)
kl267Bo01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)
kl267Ca01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)
kl267Ga01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)
kl267Hu01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)
kl267Mu01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)
kl267Po01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)
kl267Ra01组织蛋白酶K(CTSK)多克隆抗体Polyclonal Antibody to Cathepsin K (CTSK)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话